<DOC>
	<DOCNO>NCT01636024</DOCNO>
	<brief_summary>The purpose study evaluate safety profile look level AZD7594 biomarkers blood drug administer inhale healthy subject</brief_summary>
	<brief_title>To Assess Safety , Tolerability , Pharmacokinetics , Pharmacodynamics Ascending Doses Inhaled AZD7594</brief_title>
	<detailed_description>A Phase I , Single Centre , Double-blind , Randomised , Placebo-controlled , Parallel-group Study Assess Safety , Tolerability , Pharmacokinetics Pharmacodynamics After Single Multiple Ascending Inhaled Doses AZD7594 Healthy Male Volunteers</detailed_description>
	<criteria>Healthy male volunteer age 1845 year inclusive suitable vein cannulation repeat vein puncture Have body mass index ( BMI ) 18 30 kg/m2 weight 50 100 kg ( inclusive ) Be able inhale Spira nebuliser use study Be willing use condom spermicide prevent pregnancy drug exposure female partner History clinically significant disease disorder Current smokers Any clinically relevant abnormal finding</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Phase 1 ,</keyword>
	<keyword>healthy volunteer ,</keyword>
	<keyword>safety ,</keyword>
	<keyword>tolerability ,</keyword>
	<keyword>pharmacokinetics ,</keyword>
	<keyword>pharmacodynamics ,</keyword>
	<keyword>single ascend dose study ,</keyword>
	<keyword>multiple</keyword>
</DOC>